PT - JOURNAL ARTICLE AU - Kronberg, Greg AU - Ceceli, Ahmet O. AU - Huang, Yuefeng AU - Gaudreault, Pierre-Olivier AU - King, Sarah G. AU - McClain, Natalie AU - Alia-Klein, Nelly AU - Goldstein, Rita Z. TI - Naturalistic drug cue reactivity in heroin use disorder: orbitofrontal synchronization as a marker of craving and recovery AID - 10.1101/2023.11.02.23297937 DP - 2024 Jan 01 TA - medRxiv PG - 2023.11.02.23297937 4099 - http://medrxiv.org/content/early/2024/04/19/2023.11.02.23297937.short 4100 - http://medrxiv.org/content/early/2024/04/19/2023.11.02.23297937.full AB - Movies captivate groups of individuals (the audience), especially if they contain themes of common motivational interest to the group. In drug addiction, a key mechanism is maladaptive motivational salience attribution whereby drug cues outcompete other reinforcers within the same environment or context. We predicted that while watching a drug-themed movie, where cues for drugs and other stimuli share a continuous narrative context, fMRI responses in individuals with heroin use disorder (iHUD) will preferentially synchronize during drug scenes. Results revealed such drug-biased synchronization in the orbitofrontal cortex (OFC), ventromedial and ventrolateral prefrontal cortex, and insula. After 15 weeks of inpatient treatment, there was a significant reduction in this drug-biased shared response in the OFC, which correlated with a concomitant reduction in dynamically-measured craving, suggesting synchronized OFC responses to a drug-themed movie as a neural marker of craving and recovery in iHUD.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT04112186Funding StatementThis work was supported by T32MH122394 to GK, T32DA053558 to AOC, and R01AT010627 to RZG.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The institutional review board of The Icahn School of Medicine at Mount Sinai gave ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.